Full Press Release Details
CRISPR Therapeutics Proposes New Appointment to the Board of Directors.
CRSP
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
Key Takeaway: CRISPR Therapeutics Proposes New Appointment to the Board of Directors
Price reaction · baseline $42.43 (2025-01-06 close) · hit after-hours · 2 other CRSP headline(s) in the window, move may be shared
day 0 close · peak
-1.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension